Cargando…

Pharmacokinetics and Efficacy of the Spleen Tyrosine Kinase Inhibitor R406 after Ocular Delivery for Retinoblastoma

PURPOSE: Retinoblastoma is a childhood cancer of the retina. Clinical trials have shown that local delivery of broad spectrum chemotherapeutic agents is efficacious. Recent studies characterizing the genomic and epigenomic landscape of retinoblastoma identified spleen tyrosine kinase (SYK) as a prom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pritchard, Eleanor M., Stewart, Elizabeth, Zhu, Fangyi, Bradley, Cori, Griffiths, Lyra, Yang, Lei, Suryadevara, Praveen Kumar, Zhang, Jiakun, Freeman, Burgess B., Guy, R. Kiplin, Dyer, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213378/ https://www.ncbi.nlm.nih.gov/pubmed/24906597 http://dx.doi.org/10.1007/s11095-014-1399-y

Ejemplares similares

Spleen tyrosine kinase expression and its correlation with necrosis and high-risk histopathologic features in retinoblastoma
por: Yang, Ya-Li, et al.
Publicado: (2020)

Clinical Pharmacokinetics and Pharmacodynamics of Fostamatinib and Its Active Moiety R406
por: Matsukane, Ryosuke, et al.
Publicado: (2022)

Retinoblastoma from human stem cell-derived retinal organoids
por: Norrie, Jackie L., et al.
Publicado: (2021)

NS-187 (INNO-406), a Bcr-Abl/Lyn Dual Tyrosine Kinase Inhibitor
por: Niwa, Tomoko, et al.
Publicado: (2007)

Memorandum: Experiment R406
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1974)

R406 - control room
por: CERN PhotoLab
Publicado: (1975)

Non-ocular cancer in relatives of retinoblastoma patients.
por: Sanders, B. M., et al.
Publicado: (1989)

Long-term survival in 406 males with breast cancer.
por: Adami, H. O., et al.
Publicado: (1985)

Memorandum: 90$^{0}$ set up for R-406
por: Zichichi, A
Publicado: (1975)

Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients
por: Xue, Kang, et al.
Publicado: (2019)

Artificial intelligence and machine learning in ocular oncology: Retinoblastoma
por: Kaliki, Swathi, et al.
Publicado: (2023)

Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study
por: Hurwitz, Herbert I., et al.
Publicado: (2015)

Brg1 coordinates multiple processes during retinogenesis and is a tumor suppressor in retinoblastoma
por: Aldiri, Issam, et al.
Publicado: (2015)

Role of spleen tyrosine kinase in liver diseases
por: Kurniawan, Dhadhang Wahyu, et al.
Publicado: (2020)

Request for running time for experiment R406 in 1974 and 1975
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1973)

406 Living Review of World Trade Center Health Effects
por: Katruska, Alan, et al.
Publicado: (2023)

FRI406 Maternal Biomarkers Of Adiposity And Stress For Preterm Birth
por: Mayne, Gabriella, et al.
Publicado: (2023)

미군 제406의학종합연구소의 위상과 역할, 1946-1953(†)
Publicado: (2022)

Prosthetic Rehabilitation of Ocular Defect resulting from Pediatric Retinoblastoma
por: Janya, Suma, et al.
Publicado: (2014)

Custom ocular prosthesis in rehabilitation of a child operated for retinoblastoma
por: Shah, Vinit, et al.
Publicado: (2015)

Commentary: Artificial intelligence and machine learning in ocular oncology: Retinoblastoma
por: Gopal, Lingam
Publicado: (2023)

Axillary Lymph Node in Extra-Ocular Retinoblastoma – Benign or Malignant?
por: Ravindra, Shubha Gadde, et al.
Publicado: (2023)

RES2/406: Making Complex Datasets Available over the Web
por: Walker, N
Publicado: (1999)

Identification of SYK inhibitor, R406 as a novel senolytic agent
por: Cho, Hyun-Ji, et al.
Publicado: (2020)

THU406 24-hydroxylase Deficiency, A Rare Cause Of Hypercalcemia
por: Hodge, Jordesha, et al.
Publicado: (2023)

Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patients
por: Rajkumar, S, et al.
Publicado: (2023)

Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis
por: Chen, Jin-Shuen, et al.
Publicado: (2014)

Use of Preclinical Models to Improve Treatment of Retinoblastoma
por: Dyer, Michael A, et al.
Publicado: (2005)

Spleen Tyrosine Kinase Inhibition Modulates p53 Activity
por: Althubiti, Mohammad
Publicado: (2017)

An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis
por: Han, Yingjie, et al.
Publicado: (2018)

Prognostic value of spleen tyrosine kinase in human solid tumors
por: Ni, Beibei, et al.
Publicado: (2018)

Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
por: Schweig, Jonas Elias, et al.
Publicado: (2017)

406. Cloning Antibodies Against Kawasaki Disease from Acute Plasmablast Responses
por: Baron, Sarah, et al.
Publicado: (2019)

Fabrication of an Ocular Prosthesis for a Pediatric Retinoblastoma Patient by a Simplified Technique
por: Pavaiya, Arpan, et al.
Publicado: (2010)

Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma
por: Ueda, Tamaki, et al.
Publicado: (2020)

Ocular Survival Following Intravitreal Melphalan as Adjuvant Treatment for Vitreous Retinoblastoma Seeding
por: Alahmadi, Ghaida, et al.
Publicado: (2023)

Study of relativistic nucleus-nucleus collisions at the CERN SPS: addendum to memorandum M 406
por: Albrecht, R, et al.
Publicado: (1988)

MON-406 Two Cases of Aggressive Corticotroph Pituitary Tumors Treated with Capecitabine and Temozolomide
por: Tateno, Tae, et al.
Publicado: (2019)

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
por: Sato, Chihiro, et al.
Publicado: (2021)

Interaction between meteorological parameters and COVID-19: an ecological study on 406 authorities of the UK
por: Sarmadi, Mohammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q3gl5lqbqcttt3gep9bj58t5g2